703 filings
Page 18 of 36
8-K
c03c19d6yc86ugzq5
17 May 11
CytRx Completes Sale of Molecular Chaperone Assets to Orphazyme ApS in Deal Worth up to $120 Million
12:00am
8-K
72rujjeb56is7 27locc
5 May 11
CytRx Reports First Quarter 2011 Financial Results
12:00am
8-K
eiyiem2mdd0bi8 9a
11 Mar 11
CytRx Reports 2010 Financial Results
12:00am
8-K
60mgtog5 tqaz49qtqc
18 Feb 11
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
qu2nz4dx7e97w
3 Jan 11
Entry into a Material Definitive Agreement
12:00am
EFFECT
ux4f8efas
14 Dec 10
Notice of effectiveness
12:00am
UPLOAD
40i aqokhho
13 Dec 10
Letter from SEC
12:00am
CORRESP
304r3
13 Dec 10
Correspondence with SEC
12:00am
CORRESP
19fdo3et96 4r
13 Dec 10
Correspondence with SEC
12:00am
8-K
9d6gie
9 Dec 10
Entry into a Material Definitive Agreement
12:00am
8-K
xuh84xxq7mwy
8 Nov 10
CytRx Reports Third Quarter Financial Results
12:00am
UPLOAD
47qaxhws 4f
19 Oct 10
Letter from SEC
12:00am
CORRESP
luv acjoicez4qr73ve
22 Sep 10
Correspondence with SEC
12:00am
UPLOAD
45at67cpz
13 Sep 10
Letter from SEC
12:00am